First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?

Background and Purpose— There is little evidence about characteristics of ischemic stroke (IS) occurring in adults with sickle-cell disease (SCD). The objective of this study was to assess characteristics of first-ever IS in adults with SCD and to assess whether they differ from those occurring in child patients with SCD. Methods— Adult and child individuals with SCD who had a first-ever IS were identified from cohorts of patients followed up in an adult and a child sickle cell referral center. Mechanisms of IS were determined by consensus meeting from all available explorations using the following predefined classification: Vasculopathy, cardioembolism, other defined cause, and undetermined. Treatment and stroke recurrences were recorded from prospective follow-up performed in the referral centers. Results— Twenty-nine adults and 26 children had a first-ever IS; mean age (SD) was 7.1 (4.3) and 32.3 (11.6), respectively. With regard to IS mechanism, vasculopathy was less often the cause of IS in adults (12/29, 41%) than in children (24/26, 92%; P<0.001). Other causes of IS in adults were cardioembolism in 7, antiphospholipid syndrome in 1, toxic (cocaine) in 1, and undetermined in 8. Adults with SCD had a higher risk of recurrent stroke (23.1% [7.0–39.2] at 5 years) compared with children (1 recurrence only; P log rank=0.046) despite exchange-blood transfusion in patients with vasculopathy. Conclusions— First-ever IS occurring in adults with SCD has specificities that justify further studies conducted in adults with SCD to improve understanding and management.

[1]  Harold Lehmann,et al.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. , 2014, The New England journal of medicine.

[2]  Amit R. Patel,et al.  Mechanistic Insights and Characterization of Sickle Cell Disease–Associated Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.

[3]  D. Calvet,et al.  Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center , 2014, American journal of hematology.

[4]  C. Delacourt,et al.  Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. , 2011, Blood.

[5]  A. Fischer,et al.  Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. , 2007, Blood.

[6]  R. Adams,et al.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.

[7]  J. Curé,et al.  Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. , 2002, Blood.

[8]  Scott T. Miller,et al.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.

[9]  Scott T. Miller,et al.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.

[10]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[11]  S. Leikin,et al.  Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. , 1989, Pediatrics.